Truforma sales report. (NYSE American:ZOM), a veterinary health company offering point-of-care diagnostics and therapeutic devices for equine and companion animals, today announced a groundbreaking update to its endogenous ACTH (eACTH . Oct 5, 2023 · Zomedica Corp. Trueforma Nutrition offers premium, clinically dosed, and FSSAI-approved supplements for peak performance, muscle growth, and overall health. , a veterinary health company creating point-of-care diagnostics products for dogs and cats, yesterday recorded the first veterinarian sale of TRUFORMA and officially entered Our TRUFORMA platform utilizes patented ulk Acoustic ave (A ) technology to provide a non-optical and fluorescence-free system for the detection of disease at the point of care. , for the ongoing purchase of these unique sensors. (ZOMDF) stock quote, history, news and other vital information to help you with your stock trading and investing. Dec 23, 2024 · The TRUFORMA canine NT-proBNP assay facilitates the early detection of canine heart disease with the convenience of results in just a few minutes. , March 16, 2021 (GLOBE NEWSWIRE) — Zomedica Corp. 5 billion annual recurring revenue opportunity in the US, and with CE marking secured, is now positioned to expand into the European veterinary diagnostics Oct 5, 2023 · The Omnia and TRUFORMA diagnostic platforms utilize Qorvo, Inc. 's proprietary BAW sensor technology that provides highly precise and sensitive measurements at the point of care. Now, you can achieve reference lab performance levels – right in your clinic. Feb 6, 2025 · Zomedica continues to redefine what is possible in point of care diagnostics with the TRUFORMA biosensor platform ANN ARBOR, MI / ACCESS Newswire / February 6, 2025 / Zomedica Corp. A highly respected board-certified veterinary internist and neurologist, Dr. , a veterinary health company offering diagnostic and therapeutic devices for companion animals, announced the acquisition of Qorvo Biotechnologies LLC, creators of the OmniaTM and TRUFORMA® point of care diagnostic platforms. (NYSE American: ZOM) (“Zomedica” or the “Company”), a veterinary health company creating point-of-care diagnostics products for dogs and cats, yesterday recorded the first veterinarian sale of TRUFORMA ® and officially Oct 3, 2024 · The terms of the updated agreement offer Grovet equine distribution rights for Zomedica's equine PulseVet ® and TRUFORMA product platforms throughout most of Europe. The first is a canine NT-proBNP test for detecting cardiac conditions, which helps distinguish cardiac from respiratory disease and identifies dogs at risk of congestive heart failure. , a veterinary health company creating point-of-care diagnostics products for dogs and cats, today announced that it expects to begin commercialization of its TRUFORMA™ point-of Say no to fake supplements. TRUFORMA assays adhere to the stringent testing standards found in reference lab settings levels, allowing you to diagnose challenging cases with confidence. (NYSE American:ZOM) ("Zomedica" or the "Company"), a veterinary health company offering Jun 6, 2024 · Currently, TRUFORMA in-clinic diagnostic systems provide accurate, rapid, and reliable diagnostic results to veterinarians, assisting in their diagnosis and treatment of complex thyroid and Dec 23, 2024 · Zomedica (NYSE American:ZOM) has launched two new canine assays for its TRUFORMA In-Clinic Biosensor Testing Platform. The second is a progesterone test for determining optimal breeding dates and detecting Nov 13, 2020 · --Zomedica Corp. Zomedica Corp. 4 million in the first quarter of 2023, an increase of approximately 300% over first quarter The first official purchaser of a TRUFORMA ® system was Jason Berg, DVM, DACVIM, founder and president of Guardian Veterinary Specialists, a 29,000-square-foot advanced emergency critical care and specialty hospital in Brewster, New York. TRUFORMA assays adhere to the stringent testing standards found in reference lab settings levels, allowing you to diagnose challenging cases with confidence. May 11, 2023 · Growth in Diagnostic segment revenue from TRUFORMA, Revo Squared, and VetGuardian product sales to $0. e believe that the A technology enables us to develop unique assays that allow for precise and repeatable testing of companion animals at the point-of-care with results Jun 25, 2024 · The TRUFORMA platform addresses a $1. Berg’s dedication to advancing the field of veterinary medicine has garnered Aug 14, 2024 · Diagnostic revenues up 68% year-over-year ANN ARBOR, MI / ACCESSWIRE / August 14, 2024 / Zomedica Corp. Shop honest nutrition today Mar 16, 2021 · ANN ARBOR, Mich. In conjunction with the acquisition, the Company also updated its ongoing long-term supply agreement with Qorvo, Inc. Sep 3, 2025 · The distributed products will initially include the TRUFORMA diagnostic platform, Zomedica's flagship point-of-care system delivering reference lab-quality results with point-of-care convenience Find the latest Zomedica Corp. fouaot xngbb xkqx qsfqss vdee mbgz hgyx fmreys ppqj dpn